BE-13-XC52_1uM Gene Set

Dataset NIBR DRUG-seq U2OS MoA Box Gene Expression Profiles
Category transcriptomics
Type drug perturbation
Description Dose=1uM, Indolo[1,2-a]quinazolin-5(6H)-one, 7-(1H-tetrazol-5-ylmethyl)-(9CI), NAD+ ADP-Ribosyltransferase (poly(ADP-ribose)polymerase| PARP) Inhibitors targeting PARP1 (Novartis, 9904988)
External Link https://pubchem.ncbi.nlm.nih.gov/compound/9904988
Similar Terms
Downloads & Tools

Genes

17 genes differentially expressed following the BE-13-XC52_1uM drug perturbation from the NIBR DRUG-seq U2OS MoA Box dataset.

increased expression

Symbol Name Standardized Value
UBA52 ubiquitin A-52 residue ribosomal protein fusion product 1 1.02544
APRT adenine phosphoribosyltransferase 0.765015
ELOB elongin B 0.491587
RPS27 ribosomal protein S27 0.45676
UBC ubiquitin C 0.424712
RPL36 ribosomal protein L36 0.424712
RPL8 ribosomal protein L8 0.326089
RPS15 ribosomal protein S15 0.316531
RPL37A ribosomal protein L37a 0.295894
RPLP2 ribosomal protein, large, P2 0.288614
CRYAB crystallin, alpha B 0.218253
FAU Finkel-Biskis-Reilly murine sarcoma virus (FBR-MuSV) ubiquitously expressed 0.212338
RPS18 ribosomal protein S18 0.210603
C19ORF33 chromosome 19 open reading frame 33 0.208098
LDHB lactate dehydrogenase B 0.201496

decreased expression

Symbol Name Standardized Value
SMARCD1 SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 1 -0.495013
CAMKK2 calcium/calmodulin-dependent protein kinase kinase 2, beta -0.268642